4967 logo

Kobayashi Pharmaceutical Co., Ltd. Stock Price

TSE:4967 Community·JP¥400.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4967 Share Price Performance

JP¥5,330.00
-485.00 (-8.34%)
JP¥5,330.00
-485.00 (-8.34%)
Price JP¥5,330.00

4967 Community Narratives

There are no narratives available yet.

Recent 4967 News & Updates

Returns On Capital At Kobayashi Pharmaceutical (TSE:4967) Paint A Concerning Picture

Aug 27
Returns On Capital At Kobayashi Pharmaceutical (TSE:4967) Paint A Concerning Picture

Kobayashi Pharmaceutical Co., Ltd. Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Aug 08
Kobayashi Pharmaceutical Co., Ltd. Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Earnings Tell The Story For Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)

Jun 25
Earnings Tell The Story For Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)

Kobayashi Pharmaceutical Co., Ltd. Just Missed EPS By 56%: Here's What Analysts Think Will Happen Next

May 12
Kobayashi Pharmaceutical Co., Ltd. Just Missed EPS By 56%: Here's What Analysts Think Will Happen Next

Kobayashi Pharmaceutical's (TSE:4967) Returns On Capital Not Reflecting Well On The Business

Mar 18
Kobayashi Pharmaceutical's (TSE:4967) Returns On Capital Not Reflecting Well On The Business

Kobayashi Pharmaceutical Co., Ltd. Key Details

JP¥161.5b

Revenue

JP¥78.5b

Cost of Revenue

JP¥83.0b

Gross Profit

JP¥71.2b

Other Expenses

JP¥11.8b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 11, 2025
Earnings per share (EPS)
158.71
Gross Margin
51.39%
Net Profit Margin
7.31%
Debt/Equity Ratio
0%

Kobayashi Pharmaceutical Co., Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet established dividend payer.

1 Risk
2 Rewards

About 4967

Founded
1886
Employees
3615
CEO
n/a
WebsiteView website
www.kobayashi.co.jp

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, cooling gel sheets, and oral hygiene products. It also manufactures and sells pharmaceuticals, cosmetics, and health foods; and manufactures and sells synthetic resin products; markets nutritional supplements and skin care products through mail orders; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; manufacture of sanitary and paper products; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Japanese Market Performance

  • 7 Days: 2.8%
  • 3 Months: 13.9%
  • 1 Year: 16.9%
  • Year to Date: 16.8%
Over the last 7 days, the market has risen 2.8%, driven by gains of 8.0% in the Information Technology sector. The market is up 17% over the last 12 months. As for the next few years, earnings are expected to grow by 8.1% per annum. Market details ›